Trump claims credit for drug price decline, FactCheck.org finds experts say other factors explain the drop

President Donald Trump claimed credit for a 3.1% decline in prescription drug prices, citing his most-favored-nation policy and the TrumpRx platform. However, a FactCheck.org investigation found that experts largely attribute the drop to market forces, generic competition, and Biden-era Medicare price negotiations, not Trump's initiatives. The fact-check highlights misleading claims by Trump and administration officials, including CMS Administrator Mehmet Oz, and notes the limited impact of TrumpRx and the MFN deals on the overall prescription drug market.

“Under my most-favored-nation policy on drug prices, we are delivering the largest prescription drug price cuts in the history of our country.” Quote verified against source